| |
| |
|
| Insider
Information: |
Haqq Christopher |
| Relationship: |
|
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
333,924 |
|
|
Indirect Shares
|
20,000 |
|
|
| Direct
Value |
$191,084 |
|
|
|
Indirect Value
|
$10,598 |
|
|
| Total
Shares |
353,924 |
|
|
| Total
Value |
$201,682 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
EVP, R&D & Chief Scien... |
2019-02-15 |
271,943 |
2019-02-15 |
20,000 |
Premium* |
|
|
Surrozen Ord Shs |
SRZN |
Former Director |
2021-08-11 |
30,000 |
2021-08-11 |
0 |
Premium* |
|
|
Elicio Therapeutics Ord Shs |
ELTX |
|
2023-06-01 |
31,981 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SRZN |
Surrozen Ord Shs |
Former Director |
– – – |
2021-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| ELTX |
Elicio Therapeutics Ord S... |
See Remarks |
• – – |
2023-06-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
31,981 |
|
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2015-08-31 |
4 |
AS |
$41.61 |
$209,961 |
D/D |
(5,000) |
240,890 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2015-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
829 |
241,719 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2015-08-17 |
4 |
AS |
$45.75 |
$73,632 |
D/D |
(1,604) |
245,890 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2015-07-31 |
4 |
AS |
$55.43 |
$138,575 |
D/D |
(2,500) |
246,665 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2015-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
829 |
247,494 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2015-07-15 |
4 |
AS |
$62.73 |
$157,353 |
D/D |
(2,500) |
249,165 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2015-07-01 |
4 |
AS |
$50.94 |
$129,196 |
D/D |
(2,500) |
251,665 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2015-06-15 |
4 |
AS |
$44.56 |
$348,116 |
D/D |
(7,500) |
254,165 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2015-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
12,400 |
261,630 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2015-06-01 |
4 |
AS |
$40.95 |
$103,665 |
D/D |
(2,500) |
261,665 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2015-05-15 |
4 |
D |
$37.30 |
$70,385 |
D/D |
(1,887) |
264,165 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2015-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,422 |
266,052 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2019-02-06 |
4 |
D |
$38.47 |
$58,167 |
D/D |
(1,512) |
271,693 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2019-02-15 |
4 |
AS |
$39.59 |
$30,682 |
D/D |
(775) |
271,943 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2019-02-11 |
4 |
AS |
$38.55 |
$538,736 |
D/D |
(13,975) |
272,718 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2019-02-06 |
4 |
AS |
$38.04 |
$477,922 |
D/D |
(12,375) |
273,205 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2018-09-26 |
4 |
AS |
$43.08 |
$581,580 |
D/D |
(13,500) |
286,355 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP, R&D & Chief Scientific Of |
• – – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
286,693 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2016-08-15 |
4 |
AS |
$21.70 |
$30,041 |
D/D |
(1,346) |
293,948 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2016-05-16 |
4 |
AS |
$15.57 |
$24,990 |
D/D |
(1,605) |
294,465 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2016-02-16 |
4 |
AS |
$15.43 |
$49,499 |
D/D |
(3,208) |
295,240 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2016-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
829 |
295,294 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Medical Officer |
• – – |
2016-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
830 |
296,070 |
0 |
- |
|
59 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
